drugset / Trial / NCT02349763
Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction
Phase 3
Completed
260 enrolled
Department of Medical Services Ministry of Public Health of Thailand
Chulalongkorn University · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Comparison of the efficacy and side effects of intravenous and oral regimens of dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reactions in primary ovarian, fallopian tube and peritoneal cancer patients receiving first cycle of combination paclitaxel and carboplatin.
Timeline
- Start
- 2015-02-28
- Primary completion
- 2015-07-30
- Completion
- 2015-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 20 mg | Intravenous |